Parameterize and Benchmark an anti-PD-L1 Model

Webinar Details

Recorded on November 14, 2023

Speaker: Josh Apgar, PhD, Co-founder and CSO at Applied BioMath

Abstract: This is an introductory case study showing how Applied BioMath Assess™ can be used early in drug R&D to gain insight into project feasibility. Specifically in this case study, we'll discuss how to parameterize and benchmark an anti-PD-L1 model and demonstrate:

  • Setting up a model using data on PD-L1/PD1
  • Benchmarking the model using PK data for atezolizumab
  • Predicting clinical doses and determined parameters that drive that dose


View the Webinar